| Dr Gregory J Hicken, MD | |
|
2310 N 400 E, Ste A, Logan, UT 84341-1788 | |
| (435) 787-2000 | |
| (435) 787-1913 |
| Full Name | Dr Gregory J Hicken |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 37 Years |
| Location | 2310 N 400 E, Logan, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225027931 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 336606-1205 (Utah) | Primary |
| 207X00000X | Orthopaedic Surgery | M-8405 (Idaho) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dixie Home Rehab | St george, UT | Home health agency |
| Franklin County Medical Center | Preston, ID | Hospital |
| Dixie Regional Medical Center | St george, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Robotic Orthopaedic Institute St George | 5597134544 | 2 |
| Franklin County Medical Center | 8820909104 | 16 |
News Archive
Considering the ever-expanding life span of Americans, quality and compliance in post-acute care services are becoming fundamental for post-acute care facilities, as well as patients who require assisted-living services or who are recovering from a major health condition. The facilities are increasingly adopting electronic health records and using mobile phones for e-prescribing, documentation and sharing of information with patients and family. In all this, it is imperative for them to keep their facility updated about the Feds newest compliance policies and traps.
Immuno-oncology did not exist four years ago, it's a term coined by Dr. Axel Hoos, Head of the newly defined immuno-oncology department at GSK. He is also Senior Vice President Therapeutic Area (TA) and Head for Oncology R&D. Previously, it was referred to as cancer immunotherapy, but now it is called immuno-oncology (IO).
Parents of children with autism are increasingly turning to sensory integration treatment to help their children deal with the disorder, and they're seeing good results. In 2007, 71 percent of parents who pursued alternatives to traditional treatment used sensory integration methods, and 91 percent found these methods helpful.
The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy.
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today announced that they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin.
› Verified 3 days ago
| Entity Name | Alpine Management And Consulting |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427184449 PECOS PAC ID: 5496659245 Enrollment ID: O20031122000068 |
News Archive
Considering the ever-expanding life span of Americans, quality and compliance in post-acute care services are becoming fundamental for post-acute care facilities, as well as patients who require assisted-living services or who are recovering from a major health condition. The facilities are increasingly adopting electronic health records and using mobile phones for e-prescribing, documentation and sharing of information with patients and family. In all this, it is imperative for them to keep their facility updated about the Feds newest compliance policies and traps.
Immuno-oncology did not exist four years ago, it's a term coined by Dr. Axel Hoos, Head of the newly defined immuno-oncology department at GSK. He is also Senior Vice President Therapeutic Area (TA) and Head for Oncology R&D. Previously, it was referred to as cancer immunotherapy, but now it is called immuno-oncology (IO).
Parents of children with autism are increasingly turning to sensory integration treatment to help their children deal with the disorder, and they're seeing good results. In 2007, 71 percent of parents who pursued alternatives to traditional treatment used sensory integration methods, and 91 percent found these methods helpful.
The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy.
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today announced that they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin.
› Verified 3 days ago
| Entity Name | Elite Healthcare Southern Utah, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275045080 PECOS PAC ID: 4385974294 Enrollment ID: O20190919000321 |
News Archive
Considering the ever-expanding life span of Americans, quality and compliance in post-acute care services are becoming fundamental for post-acute care facilities, as well as patients who require assisted-living services or who are recovering from a major health condition. The facilities are increasingly adopting electronic health records and using mobile phones for e-prescribing, documentation and sharing of information with patients and family. In all this, it is imperative for them to keep their facility updated about the Feds newest compliance policies and traps.
Immuno-oncology did not exist four years ago, it's a term coined by Dr. Axel Hoos, Head of the newly defined immuno-oncology department at GSK. He is also Senior Vice President Therapeutic Area (TA) and Head for Oncology R&D. Previously, it was referred to as cancer immunotherapy, but now it is called immuno-oncology (IO).
Parents of children with autism are increasingly turning to sensory integration treatment to help their children deal with the disorder, and they're seeing good results. In 2007, 71 percent of parents who pursued alternatives to traditional treatment used sensory integration methods, and 91 percent found these methods helpful.
The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy.
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today announced that they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin.
› Verified 3 days ago
| Entity Name | Robotic Orthopaedic Institute St George |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598426314 PECOS PAC ID: 5597134544 Enrollment ID: O20221213003063 |
News Archive
Considering the ever-expanding life span of Americans, quality and compliance in post-acute care services are becoming fundamental for post-acute care facilities, as well as patients who require assisted-living services or who are recovering from a major health condition. The facilities are increasingly adopting electronic health records and using mobile phones for e-prescribing, documentation and sharing of information with patients and family. In all this, it is imperative for them to keep their facility updated about the Feds newest compliance policies and traps.
Immuno-oncology did not exist four years ago, it's a term coined by Dr. Axel Hoos, Head of the newly defined immuno-oncology department at GSK. He is also Senior Vice President Therapeutic Area (TA) and Head for Oncology R&D. Previously, it was referred to as cancer immunotherapy, but now it is called immuno-oncology (IO).
Parents of children with autism are increasingly turning to sensory integration treatment to help their children deal with the disorder, and they're seeing good results. In 2007, 71 percent of parents who pursued alternatives to traditional treatment used sensory integration methods, and 91 percent found these methods helpful.
The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy.
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today announced that they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory J Hicken, MD 2310 N 400 E, Ste A, Logan, UT 84341-1788 Ph: (435) 787-2000 | Dr Gregory J Hicken, MD 2310 N 400 E, Ste A, Logan, UT 84341-1788 Ph: (435) 787-2000 |
News Archive
Considering the ever-expanding life span of Americans, quality and compliance in post-acute care services are becoming fundamental for post-acute care facilities, as well as patients who require assisted-living services or who are recovering from a major health condition. The facilities are increasingly adopting electronic health records and using mobile phones for e-prescribing, documentation and sharing of information with patients and family. In all this, it is imperative for them to keep their facility updated about the Feds newest compliance policies and traps.
Immuno-oncology did not exist four years ago, it's a term coined by Dr. Axel Hoos, Head of the newly defined immuno-oncology department at GSK. He is also Senior Vice President Therapeutic Area (TA) and Head for Oncology R&D. Previously, it was referred to as cancer immunotherapy, but now it is called immuno-oncology (IO).
Parents of children with autism are increasingly turning to sensory integration treatment to help their children deal with the disorder, and they're seeing good results. In 2007, 71 percent of parents who pursued alternatives to traditional treatment used sensory integration methods, and 91 percent found these methods helpful.
The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy.
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today announced that they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin.
› Verified 3 days ago
Bryan C King, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1300 N 500 E, #130, Logan, UT 84341 Phone: 435-716-2800 | |
Dr. Joseph Jay Stuart, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-716-2800 | |
Edwin Marlowe Goble, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 274 N Main St, Logan, UT 84321 Phone: 435-753-1600 Fax: 435-753-9521 | |
Dr. Keith J Nelson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2310 N 400 E, Ste A, Logan, UT 84341 Phone: 435-787-2000 Fax: 435-787-1913 | |
Dr. Brian A. Vernon, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 630 E 1400 N Ste 118, Logan, UT 84341 Phone: 435-799-7953 Fax: 435-514-7977 | |
Dr. Terry I Finlayson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2310 N 400 E, Logan, UT 84341 Phone: 435-787-2000 Fax: 435-787-1913 |